glp 1 for people who are not obese if GLP-1 medications changing the conversation around obesity care—but glp 1 if not overweight

These drugs, originally meant to treat diabetes, have become widely known for their slimming side effects

2022Oct;15(189):15562

In brief, the gradient started with 5% buffer B and increased stepwise to 45% over 45 min, followed by a wash-out at 95% buffer B, all at a flowrate of 300 nl min 1

11 Every meal and snack should be viewed as an opportunity to provide the body with the essential building blocks it needs to function optimally, support fat loss, and preserve vital muscle tissue

Zinman B, Wanner C, Lachin JM et al (2015) Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes

Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, American Association of Clinical Endocrinologists